Page last updated: 2024-12-05

salicylaldoxime

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Salicylaldoxime is an organic compound that is a white crystalline solid with a melting point of 57-58 °C. It is an important chelating agent, meaning it can bind to metal ions, particularly those of transition metals such as copper and nickel. This property makes salicylaldoxime useful in various applications, including: 1) Analytical chemistry: Salicylaldoxime is used for the gravimetric determination of copper, nickel, and other metals. It forms colored complexes with these metals, allowing for their quantitative analysis. 2) Extraction and separation: Salicylaldoxime can be used for the extraction and separation of metal ions from various solutions. Its selective binding to certain metals allows for their isolation and purification. 3) Catalysis: Salicylaldoxime exhibits catalytic activity in various reactions, such as oxidation and reduction reactions. Its ability to coordinate with metal ions can enhance their catalytic efficiency. 4) Medical applications: Salicylaldoxime has been investigated for potential medical applications, particularly in the treatment of cancer and bacterial infections. However, its clinical use is still under development. The synthesis of salicylaldoxime typically involves the reaction of salicylaldehyde with hydroxylamine hydrochloride in the presence of a base such as sodium hydroxide. The reaction proceeds via the formation of an intermediate oxime, which is then dehydrated to yield the final product. Salicylaldoxime is a valuable reagent with diverse applications, primarily related to its metal-binding properties. Its ability to form complexes with metal ions makes it useful in analytical chemistry, extraction, and catalysis. Further research is ongoing to explore its potential in medicine.'

Cross-References

ID SourceID
PubMed CID7200
SCHEMBL ID5348198
MeSH IDM0047422

Synonyms (10)

Synonym
2-hydroxybenzaldehyde oxime
94-67-7
salicylaldoxime ,
2-hydroxybenzaldehyde-oxime
salicylideneaminoalcohol
SCHEMBL5348198
AKOS025243587
DTXSID9052638
o-hydroxyphenylnitrone
2-(hydroxyiminomethyl)phenol

Research Excerpts

Overview

Salicylaldoxime is a potent inhibitor of in vitro anaphylaxis in guinea pig lung, but phlorizin is only a weak inhibitor.

ExcerptReferenceRelevance
"Salicylaldoxime is a potent inhibitor of in vitro anaphylaxis in guinea pig lung, but phlorizin is only a weak inhibitor."( Anaphylaxis in chopped guinea pig lung. III. Effect of carbon monoxide, cyanide, salicylaldoxime, and ionic strength.
AUSTEN, KF; BROCKLEHURST, WE, 1961
)
1.19

Effects

ExcerptReferenceRelevance
"Salicylaldoxime has been found to have a variety of concentration-dependent effects on chloroplast activities. "( Concentration-dependent effects of salicylaldoxime on chloroplast reactions.
Berg, SP; Izawa, S, 1976
)
1.98
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (20.00)18.7374
1990's3 (8.57)18.2507
2000's8 (22.86)29.6817
2010's16 (45.71)24.3611
2020's1 (2.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.86 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index44.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (94.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]